Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Chronic Kidney Diseases: early-phase trial registry
46 of 74 indexed Chronic Kidney Diseases trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #183 of 28,707 conditions by registered trial count.
74 US clinical trials · 46 currently recruiting · #183 of 28,707 conditions by registered trial count
Chronic Kidney Diseases: 74 US clinical trials tracked, 46 recruiting.
Chronic Kidney Diseases is the subject of 74 registered US clinical trials on ClinicalTrials.gov, 46 of them currently open to new participants. 6 are in Phase 3-4 (later-stage) and 15 in Phase 1-2 (earlier-stage). The most active sponsor is Brigham and Women's Hospital, running 6 of these trials.
Enrollment posture brief
Registry condition chronic-kidney-diseases
OPEN 46 | RECR 62% | LATE 6 | EARLY 15 | RANK #183 | SPON 6
Volume-matched condition peers
Nearest open-share peer: Advanced Breast Cancer (62% recruiting · 29 trials)
Chronic Kidney Diseases lists 46 open slots (62% of 74 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Chronic Kidney Diseases on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Chronic Kidney Diseases is recruiting above its size-band peers.
46 of 74 indexed trials (62.2%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Chronic Kidney Diseases trials is spread across many organizations.
Brigham and Women's Hospital accounts for 6 of 74 trials (8.1%). 53 distinct sponsors appear on at least one study for this condition label.
-
Typical Chronic Kidney Diseases enrolment sits around 108 participants.
Median target enrolment is 108 among the 74 trials that report a genuine target (sentinel values excluded). 35 of those (47.3%) plan for fewer than 100 participants.
-
Chronic Kidney Diseases research is mostly interventional.
59 interventional and 15 observational studies make up this index (79.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
74 total, page 1 of 2
Real World Evidence Clinical Utility Study of KidneyIntelX
Renalytix AI
NCT04802395
Home Hospital for Suddenly Ill Adults
Brigham and Women's Hospital
NCT03524222
Kidney Precision Medicine Project
University of Washington
NCT04334707
Care Transitions App for Patients With Multiple Chronic Conditions
Brigham and Women's Hospital
NCT06051058
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
Prokidney
NCT05099770
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
VenoStent
NCT06001827
APOL1 Genetic Testing in African Americans
St. Louis University
NCT05656261
American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
University of New Mexi
NCT04185844
Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads
University of South Carolina
NCT05370014
A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities
Johns Hopkins University
NCT05321368
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
University of Tennessee
NCT06374277
Kidney Health: Eat Well, Live Well
University of Texas at Austin
NCT05970341
Mixed Methods Study of Health-Related Social Needs in African American Adults With Chronic Kidney Disease and Type 2 Diabetes Mellitus
Medical College of Wisconsin
NCT05692388
Chronic Kidney Disease-Education (CKD-EDU)
University of Rochester
NCT06410144
Partners Calciphylaxis Biobank
Massachusetts General Hospital
NCT03032835
BLOOM: Biological Legacy of Origin in Mother-Infant Dyads
University of Miami
NCT02000895
Combination of Novel Therapies for CKD Comorbid Depression
Stony Brook University
NCT04422652
SPYRAL GEMINI Pilot Study
Medtronic Vascular
NCT06907147
Ferric Citrate and Chronic Kidney Disease in Children
University of California, Los Angeles
NCT04741646
Sit Less, Interact and Move More (SLIMM) 2 Study
Srinvasan Beddhu
NCT05173714
Mindfulness in Chronic Kidney Disease
Emory University
NCT04099992
Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity
Columbia University
NCT05655325
Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease
Brigham and Women's Hospital
NCT06190158
Interactive Computer-adaptive Chronic Kidney Disease Education Program
University of Chicago
NCT06364358
Inspiratory Muscle Strength Training in Chronic Kidney Disease
University of Colorado, Denver
NCT04911491
Bone in CKD Alkali Response (BICARb Pilot Trial)
Albert Einstein College of Medicine
NCT05918029
Physical Activity in CKD
Children's Hospital of Philadelphia
NCT06624358
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
University of California, Davis
NCT04984226
A Long-Term Follow-Up Study of Participants Exposed to REACT
Prokidney
NCT05918523
A Pilot Study of The CKM JumpStart Tool
University of Washington
NCT05753020
Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
Mayo Clinic
NCT06752577
Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease
Duke University
NCT05237388
Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease
Northwestern University
NCT05719714
Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD
Washington D.C. Veterans Affairs Medical Center
NCT06110130
Handgrip Exercise Training and CKD
Emory University
NCT07094906
Oral Iron in Children With Chronic Kidney Disease
Weill Medical College of Cornell University
NCT03991169
Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease
Ann & Robert H Lurie Children's Hospital of Chicago
NCT06430684
Precision Medicine Approaches to Renal Osteodystrophy
Thomas Nickolas
NCT05880914
Acute Equol Supplementation and Vascular Function in Women With and Without CKD
University of Colorado, Denver
NCT06128278
Enhancing Physical Function in Older Adults With Chronic Kidney Disease
Wake Forest University Health Sciences
NCT06738394
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Chronic Kidney Disease (CKD)
NYU Langone Health
NCT06927024
Concomitant Renal and Urinary Bladder Allograft Transplantation
Mayo Clinic
NCT04626167
Diuretic Tuner Clinical Decision Support
University of Texas Southwestern Medical Center
NCT04759274
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
The University of Texas at Arlington
NCT03471117
Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine
Brigham and Women's Hospital
NCT04500665
Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants
University of California, Los Angeles
NCT05525507
Prospective Decision Impact Clinical Utility Trial of KidneyIntelX
Renalytix AI
NCT05198284
Patient Education Video to Reduce OTC NSAIDs
Carilion Clinic
NCT06575205
SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN
Medtronic Vascular
NCT05198674
BRINK (BRain In Kidney Disease) Memory Study 2.0
Anne Murray
NCT04975464
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 7 |
| Phase 2 | 8 |
| Phase 3 | 1 |
| Phase 4 | 5 |
Top Sponsors
Named interventions
Most-linked intervention names on Chronic Kidney Diseases records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Chronic Kidney Diseases trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Chronic Kidney Diseases page
74 registered trials, 46 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 46 Chronic Kidney Diseases trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Brigham and Women's Hospital sponsors the most Chronic Kidney Diseases trials on record, review their full trial history before evaluating a specific study. See Brigham and Women's Hospital's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chronic Kidney Diseases condition card totals 74 registered trials; most-linked intervention Placebo; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.